Sean E. Browne - 15 Oct 2023 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role: President and CEO, Director
Signature: /s/ Amy Culbert, attorney-in-fact
Issuer symbol: XTNT
Transactions as of: 15 Oct 2023
Net transactions value: -$120,659
Form type: 4
Filing time: 17 Oct 2023, 16:43:14 UTC
Previous filing: 17 Aug 2023
Next filing: 05 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XTNT	Common Stock	Tax liability	$120,659	-111,721	-6.6%	$1.08	1,569,079	15 Oct 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 174,216 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares to be issued upon vesting pursuant to restricted stock awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended from time to time, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.

Content

Includes 174,216 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares to be issued upon vesting pursuant to restricted stock awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended from time to time, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.